204 related articles for article (PubMed ID: 3539709)
1. Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.
Rossi Fanelli F; Cangiano C; Capocaccia L; Cascino A; Ceci F; Muscaritoli M; Giunchi G
Gut; 1986 Nov; 27 Suppl 1(Suppl 1):111-5. PubMed ID: 3539709
[TBL] [Abstract][Full Text] [Related]
2. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
[TBL] [Abstract][Full Text] [Related]
3. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
[TBL] [Abstract][Full Text] [Related]
4. Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study.
Rossi-Fanelli F; Riggio O; Cangiano C; Cascino A; De Conciliis D; Merli M; Stortoni M; Giunchi G
Dig Dis Sci; 1982 Oct; 27(10):929-35. PubMed ID: 6749458
[TBL] [Abstract][Full Text] [Related]
5. Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.
Eriksson LS; Persson A; Wahren J
Gut; 1982 Oct; 23(10):801-6. PubMed ID: 6749604
[TBL] [Abstract][Full Text] [Related]
6. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.
Marchesini G; Dioguardi FS; Bianchi GP; Zoli M; Bellati G; Roffi L; Martines D; Abbiati R
J Hepatol; 1990 Jul; 11(1):92-101. PubMed ID: 2204661
[TBL] [Abstract][Full Text] [Related]
7. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis.
Vilstrup H; Gluud C; Hardt F; Kristensen M; Køhler O; Melgaard B; Dejgaard A; Hansen BA; Krintel JJ; Schütten HJ
J Hepatol; 1990 May; 10(3):291-6. PubMed ID: 2195106
[TBL] [Abstract][Full Text] [Related]
8. [Valine and branched-chain amino acids in the treatment of hepatic encephalopathy].
Grüngreiff K; Kleine FD; Musil HE; Diete U; Franke D; Klauck S; Päge I; Kleine S; Lössner B; Pfeiffer KP
Z Gastroenterol; 1993 Apr; 31(4):235-41. PubMed ID: 8493803
[TBL] [Abstract][Full Text] [Related]
9. Branched-chain amino acids for hepatic encephalopathy.
Als-Nielsen B; Koretz RL; Kjaergard LL; Gluud C
Cochrane Database Syst Rev; 2003; (2):CD001939. PubMed ID: 12804416
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of hepatic coma probably caused by acute infectious hepatitis with balanced solution of amino acids.
Frydén A; Weiland O; Mårtensson J
Scand J Infect Dis; 1982; 14(3):177-80. PubMed ID: 7146828
[TBL] [Abstract][Full Text] [Related]
11. Selective amono acid solutions in hepatic encephalopathy treatment (a preliminary report).
Fiaccadori F; Ghinelli F; Pelosi G; Sacchini D; Vaona GL; Zeneroli ML; Rocchi E; Santunione V; Gibertini P; Ventura E
Ric Clin Lab; 1980; 10(2):411-22. PubMed ID: 7455531
[TBL] [Abstract][Full Text] [Related]
12. Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants.
Eriksson LS; Conn HO
Hepatology; 1989 Aug; 10(2):228-46. PubMed ID: 2663696
[No Abstract] [Full Text] [Related]
13. Oral keto analogs of branched-chain amino acids in hyperammonemia in patients with cirrhosis of the liver. A double-blind crossover study.
Walker S; Götz R; Czygan P; Stiehl A; Lanzinger G; Sieg A; Raedsch R; Kommerell B
Digestion; 1982; 24(2):105-11. PubMed ID: 7128954
[TBL] [Abstract][Full Text] [Related]
14. The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy.
Herlong HF; Maddrey WC; Walser M
Ann Intern Med; 1980 Oct; 93(4):545-50. PubMed ID: 7001971
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of hepatic encephalopathy with oral branched-chain amino acids: I. Acute hepatic encephalopathy].
Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A
Rev Esp Enferm Apar Dig; 1987 Aug; 72(2):116-22. PubMed ID: 3659529
[No Abstract] [Full Text] [Related]
16. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study.
Egberts EH; Schomerus H; Hamster W; Jürgens P
Gastroenterology; 1985 Apr; 88(4):887-95. PubMed ID: 3882509
[TBL] [Abstract][Full Text] [Related]
17. Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids.
Chalasani N; Gitlin N
Am J Gastroenterol; 1996 Jun; 91(6):1266-8. PubMed ID: 8651189
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hepatic encephalopathy with branched-chain amino acids (BCAA) by oral route: II. Chronic hepatic encephalopathy].
Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A
Rev Esp Enferm Apar Dig; 1987 Sep; 72(3):201-5. PubMed ID: 3685578
[No Abstract] [Full Text] [Related]
19. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study.
Plauth M; Egberts EH; Hamster W; Török M; Müller PH; Brand O; Fürst P; Dölle W
J Hepatol; 1993 Mar; 17(3):308-14. PubMed ID: 8315258
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
Kawaguchi T; Taniguchi E; Sata M
Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]